Asset Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Buy |
47,678
+2,697
| +6% | +$71.8K | 0.22% | 81 |
|
|
2025
Q4 | $1.12M | Sell |
44,981
-1,428
| -3% | -$36K | 0.18% | 85 |
|
|
2025
Q3 | $1.18M | Buy |
46,409
+993
| +2% | +$24.5K | 0.19% | 85 |
|
|
2025
Q2 | $1.1M | Buy |
45,416
+578
| +1% | +$13.5K | 0.19% | 86 |
|
|
2025
Q1 | $1.14M | Sell |
44,838
-1,799
| -4% | -$47.1K | 0.21% | 81 |
|
|
2024
Q4 | $1.24M | Sell |
46,637
-5,241
| -10% | -$142K | 0.22% | 77 |
|
|
2024
Q3 | $1.5M | Buy |
51,878
+875
| +2% | +$25.5K | 0.26% | 75 |
|
|
2024
Q2 | $1.43M | Buy |
51,003
+683
| +1% | +$18.8K | 0.27% | 74 |
|
|
2024
Q1 | $1.4M | Buy |
50,320
+740
| +1% | +$20.5K | 0.26% | 73 |
|
|
2023
Q4 | $1.43M | Sell |
49,580
-695
| -1% | -$21K | 0.29% | 72 |
|
|
2023
Q3 | $1.67M | Sell |
50,275
-1,267
| -2% | -$44.8K | 0.37% | 66 |
|
|
2023
Q2 | $1.89M | Sell |
51,542
-102
| -0.2% | -$3.97K | 0.4% | 65 |
|
|
2023
Q1 | $2.11M | Buy |
51,644
+203
| +0.4% | +$8.77K | 0.47% | 61 |
|
|
2022
Q4 | $2.64M | Buy |
51,441
+375
| +0.7% | +$18K | 0.62% | 51 |
|
|
2022
Q3 | $2.23M | Buy |
51,066
+406
| +0.8% | +$19.7K | 0.56% | 53 |
|
|
2022
Q2 | $2.66M | Buy |
50,660
+382
| +0.8% | +$19.5K | 0.64% | 47 |
|
|
2022
Q1 | $2.6M | Buy |
50,278
+379
| +0.8% | +$19.7K | 0.54% | 51 |
|
|
2021
Q4 | $2.95M | Buy |
49,899
+218
| +0.4% | +$10.8K | 0.58% | 51 |
|
|
2021
Q3 | $2.14M | Buy |
49,681
+4,764
| +11% | +$211K | 0.44% | 62 |
|
|
2021
Q2 | $1.76M | Buy |
44,917
+401
| +0.9% | +$15.6K | 0.36% | 66 |
|
|
2021
Q1 | $1.61M | Buy |
44,516
+451
| +1% | +$16K | 0.35% | 70 |
|
|
2020
Q4 | $1.62M | Sell |
44,065
-1,990
| -4% | -$73K | 0.39% | 64 |
|
|
2020
Q3 | $1.6M | Buy |
46,055
+425
| +0.9% | +$14.9K | 0.47% | 59 |
|
|
2020
Q2 | $1.42M | Buy |
45,630
+2,548
| +6% | +$86.6K | 0.45% | 57 |
|
|
2020
Q1 | $1.33M | Sell |
43,082
-282
| -0.7% | -$9.61K | 0.5% | 56 |
|
|
2019
Q4 | $1.61M | Buy |
43,364
+351
| +0.8% | +$12.5K | 0.49% | 57 |
|
|
2019
Q3 | $1.47M | Sell |
43,013
-776
| -2% | -$28.2K | 0.5% | 54 |
|
|
2019
Q2 | $1.8M | Sell |
43,789
-3,275
| -7% | -$130K | 0.64% | 45 |
|
|
2019
Q1 | $1.9M | Buy |
47,064
+342
| +0.7% | +$13.7K | 0.69% | 45 |
|
|
2018
Q4 | $1.94M | Buy |
46,722
+7,680
| +20% | +$319K | 0.79% | 41 |
|
|
2018
Q3 | $1.63M | Buy |
39,042
+273
| +0.7% | +$10.5K | 0.55% | 50 |
|
|
2018
Q2 | $1.33M | Sell |
38,769
-66
| -0.2% | -$2.25K | 0.47% | 53 |
|
|
2018
Q1 | $1.31M | Buy |
38,835
+294
| +0.8% | +$10.1K | 0.47% | 54 |
|
|
2017
Q4 | $1.32M | Sell |
38,541
-1,145
| -3% | -$39K | 0.48% | 54 |
|
|
2017
Q3 | $1.34M | Sell |
39,686
-2,137
| -5% | -$68.7K | 0.5% | 53 |
|
|
2017
Q2 | $1.33M | Sell |
41,823
-896
| -2% | -$28.3K | 0.52% | 53 |
|
|
2017
Q1 | $1.39M | Buy |
42,719
+947
| +2% | +$29.9K | 0.55% | 53 |
|
|
2016
Q4 | $1.29M | Sell |
41,772
-434
| -1% | -$13.2K | 0.53% | 53 |
|
|
2016
Q3 | $1.36M | Buy |
42,206
+322
| +0.8% | +$10.8K | 0.56% | 51 |
|
|
2016
Q2 | $1.4M | Sell |
41,884
-311
| -0.7% | -$9.93K | 0.61% | 50 |
|
|
2016
Q1 | $1.19M | Buy |
42,195
+1,956
| +5% | +$55.9K | 0.53% | 51 |
|
|
2015
Q4 | $1.23M | Buy |
40,239
+305
| +0.8% | +$9.6K | 0.56% | 50 |
|
|
2015
Q3 | $1.19M | Buy |
39,934
+173
| +0.4% | +$5.55K | 0.56% | 50 |
|
|
2015
Q2 | $1.26M | Buy |
39,761
+308
| +0.8% | +$10K | 0.57% | 46 |
|
|
2015
Q1 | $1.3M | Buy |
39,453
+502
| +1% | +$16K | 0.6% | 46 |
|
|
2014
Q4 | $1.15M | Buy |
38,951
+287
| +0.7% | +$8.23K | 0.58% | 42 |
|
|
2014
Q3 | $1.08M | Buy |
38,664
+296
| +0.8% | +$8.31K | 0.58% | 43 |
|
|
2014
Q2 | $1.08M | Buy |
38,368
+4,833
| +14% | +$138K | 0.58% | 42 |
|
|
2014
Q1 | $1.02M | Buy |
33,535
+1,090
| +3% | +$32.5K | 0.59% | 43 |
|
|
2013
Q4 | $943K | Buy |
32,445
+838
| +3% | +$24.4K | 0.57% | 42 |
|
|
2013
Q3 | $861K | Buy |
31,607
+674
| +2% | +$18.3K | 0.56% | 40 |
|
|
2013
Q2 | $822K | Buy |
+30,933
| New | +$855K | 0.56% | 40 |
|
Other funds holding PFE
VCM
VPM
Asset Management Group's PFE Position: Q1 2026 in Review
Asset Management Group increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $71.8K and bringing the position to 47,678 shares worth $1.34M. The position accounts for 0.22% of the portfolio, ranked #81.
Asset Management Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.95M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Asset Management Group held 47,678 shares of Pfizer worth $1.34M as of Q1 2026.
- Asset Management Group bought 2,697 Pfizer shares in Q1 2026, an estimated $71.8K.
- Pfizer made up 0.22% of Asset Management Group's portfolio in Q1 2026, its #81 holding.
- Asset Management Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Asset Management Group's Pfizer position peaked at $2.95M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Asset Management Group's 13F filing for Q1 2026, filed 15 May 2026.